|
|
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Department of Medicinal Chemistry and Molecular Pharmacology, School of Pharmacy and Pharmacal Sciences (N.H., G.H.H.) and Graduate Program in Biochemistry and Molecular Biology (N.D.), Purdue University, West Lafayette, Indiana
Verapamil block of Cav1.2 is frequency-dependent and potentiated by Ca2+. We examined the molecular determinants of these characteristics using mutations that effect Ca2+ interactions with Cav1.2. Mutant and wild-type Cav1.2 channels were transiently expressed in tsA 201 cells with
1b and
2
subunits. The four conserved glutamates that compose the Ca2+ selectivity filter in Cav1.2 were mutated to Gln (E363Q, E709Q, E1118Q, E1419Q) and the adjacent conserved threonine in each domain was mutated to Ala (T361A, T707A, T1116A, T1417A). The L-type-specific residues in the domain III pore region (F1117G) and the C-terminal tail (I1627A) were also mutated and assayed for block by verapamil using whole-cell voltage-clamp recordings in 10 mM Ba2+ or 10 mM Ca2+. In Ba2+, none of the pore-region mutations reduced the fraction of current blocked by 30 µM verapamil at 0.05 Hz stimulation. However, all of the pore-region mutations abolished Ca2+ potentiation of verapamil block at 0.05 Hz. The T1116A, F1117G, E1118Q, and E1419Q mutations all significantly reduced frequency-dependent verapamil block (1-Hz stimulation) in both Ba2+ and Ca2+. The I1627A mutation, which disrupts Ca2+-dependent inactivation, increased the fraction of closed channels blocked by 30 µM verapamil in Ba2+ but did not affect frequency-dependent block in Ba2+ or Ca2+. Our data suggest that the pore region of domain III may contribute to a high affinity verapamil binding site accessed during 1-Hz stimulation and that Ca2+ binding to multiple sites may be required for potentiation of verapamil block of closed channels.
Address correspondence to: Gregory Hockerman, 575 Stadium Mall Dr., West Lafayette, IN 47907-2091. E-mail: gregh{at}pharmacy.purdue.edu
This article has been cited by other articles:
![]() |
D. B. Tikhonov and B. S. Zhorov Molecular Modeling of Benzothiazepine Binding in the L-type Calcium Channel J. Biol. Chem., June 20, 2008; 283(25): 17594 - 17604. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Beyl, E. N. Timin, A. Hohaus, A. Stary, M. Kudrnac, R. H. Guy, and S. Hering Probing the Architecture of an L-type Calcium Channel with a Charged Phenylalkylamine: EVIDENCE FOR A WIDELY OPEN PORE AND DRUG TRAPPING J. Biol. Chem., February 9, 2007; 282(6): 3864 - 3870. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. S. Freeze, M. M. McNulty, and D. A. Hanck State-Dependent Verapamil Block of the Cloned Human Cav3.1 T-Type Ca2+ Channel Mol. Pharmacol., August 1, 2006; 70(2): 718 - 726. [Abstract] [Full Text] [PDF] |
||||